Adults with pathogenic copy number variants more likely to have poorer health, study suggests

Adults with specific genetic causes of mental health and other brain disorders had significantly higher rates of chronic disease and twice as many annual emergency room visits when compared to a control group without these genetic conditions, a Geisinger study found.

Rare genetic changes, known as pathogenic copy number variants (pCNVs), have large effects on brain function and are known underlying causes of autism spectrum disorder, intellectual disability, schizophrenia, epilepsy and other brain disorders. Researchers have found several dozen pCNVs associated with these conditions, but little research has been done on healthcare utilization in adults with these genetic changes.

The Geisinger research team compared a group of 928 adults who had one of these pCNVs to a control group from Geisinger's MyCode Community Health Initiative who did not have a pCNV. The study found that adults with one of these genetic conditions were more likely than the control group to have a documented neurodevelopmental or psychiatric disorder, and had higher rates of diabetes, dementia and other chronic health conditions. Adults with a pCNV also recorded twice as many annual emergency room visits.

The results were published this month in Genetics in Medicine.

These findings suggest that adults with pathogenic copy number variants have poorer health and require disproportionate healthcare resources. Early genetic diagnosis paired with patient-centered interventions may help to anticipate these health conditions, improve outcomes and reduce the associated economic burden for these patients."

Brenda Finucane, M.S., professor at Geisinger's Autism & Developmental Medicine Institute and lead author of the study

Source:
Journal reference:

Finucane, B., et al. (2021) Medical manifestations and health care utilization among adult MyCode participants with neurodevelopmental psychiatric copy number variants. Genetics in Medicine. doi.org/10.1016/j.gim.2021.11.010.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Semaglutide reduces urine albumin-to-creatinine ratio in overweight chronic kidney disease patients